Literature DB >> 33481867

Fluorescent detection of PARP activity in unfixed tissue.

Soumaya Belhadj1, Andreas Rentsch2, Frank Schwede2, François Paquet-Durand1.   

Abstract

Poly-ADP-ribose-polymerase (PARP) relates to a family of enzymes that can detect DNA breaks and initiate DNA repair. While this activity is generally seen as promoting cell survival, PARP enzymes are also known to be involved in cell death in numerous pathologies, including in inherited retinal degeneration. This ambiguous role of PARP makes it attractive to have a simple and fast enzyme activity assay, that allows resolving its enzymatic activity in situ, in individual cells, within complex tissues. A previously published two-step PARP activity assay uses biotinylated NAD+ and streptavidin labelling for this purpose. Here, we used the fluorescent NAD+ analogues ε-NAD+ and 6-Fluo-10-NAD+ to assess PARP activity directly on unfixed tissue sections obtained from wild-type and retinal degeneration-1 (rd1) mutant retina. In standard UV microscopy ε-NAD+ incubation did not reveal PARP specific signal. In contrast, 6-Fluo-10-NAD+ resulted in reliable detection of in situ PARP activity in rd1 retina, especially in the degenerating photoreceptor cells. When the 6-Fluo-10-NAD+ based PARP activity assay was performed in the presence of the PARP specific inhibitor olaparib, the activity signal was completely abolished, attesting to the specificity of the assay. The incubation of live organotypic retinal explant cultures with 6-Fluo-10-NAD+, did not produce PARP specific signal, indicating that the fluorescent marker may not be sufficiently membrane-permeable to label living cells. In summary, we present a new, rapid, and simple to use fluorescence assay for the cellular resolution of PARP activity on unfixed tissue, for instance in complex neuronal tissues such as the retina.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33481867      PMCID: PMC7822349          DOI: 10.1371/journal.pone.0245369

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  34 in total

1.  Erasable blot of poly(ADP-ribose) polymerase.

Authors:  S Desnoyers; G M Shah; G Brochu; G G Poirier
Journal:  Anal Biochem       Date:  1994-05-01       Impact factor: 3.365

Review 2.  Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors.

Authors:  Prakash Jagtap; Csaba Szabó
Journal:  Nat Rev Drug Discov       Date:  2005-05       Impact factor: 84.694

3.  Olaparib hydroxamic acid derivatives as dual PARP and HDAC inhibitors for cancer therapy.

Authors:  Zigao Yuan; Shaopeng Chen; Qinsheng Sun; Ning Wang; Dan Li; Shuangshuang Miao; Chunmei Gao; Yuzong Chen; Chunyan Tan; Yuyang Jiang
Journal:  Bioorg Med Chem       Date:  2017-05-31       Impact factor: 3.641

4.  In situ staining for poly(ADP-ribose) polymerase activity using an NAD analogue.

Authors:  R E Davis; V Mysore; J C Browning; J C Hsieh; Q A Lu; P D Katsikis
Journal:  J Histochem Cytochem       Date:  1998-11       Impact factor: 2.479

5.  Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor.

Authors:  Seong-Woon Yu; Hongmin Wang; Marc F Poitras; Carmen Coombs; William J Bowers; Howard J Federoff; Guy G Poirier; Ted M Dawson; Valina L Dawson
Journal:  Science       Date:  2002-07-12       Impact factor: 47.728

6.  Calpain and PARP activation during photoreceptor cell death in P23H and S334ter rhodopsin mutant rats.

Authors:  Jasvir Kaur; Stine Mencl; Ayse Sahaboglu; Pietro Farinelli; Theo van Veen; Eberhart Zrenner; Per Ekström; François Paquet-Durand; Blanca Arango-Gonzalez
Journal:  PLoS One       Date:  2011-07-12       Impact factor: 3.240

Review 7.  Olaparib in the management of ovarian cancer.

Authors:  Kristin Bixel; John L Hays
Journal:  Pharmgenomics Pers Med       Date:  2015-08-07

8.  Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration.

Authors:  Blanca Arango-Gonzalez; Dragana Trifunović; Ayse Sahaboglu; Katharina Kranz; Stylianos Michalakis; Pietro Farinelli; Susanne Koch; Fred Koch; Sandra Cottet; Ulrike Janssen-Bienhold; Karin Dedek; Martin Biel; Eberhart Zrenner; Thomas Euler; Per Ekström; Marius Ueffing; François Paquet-Durand
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

9.  Olaparib significantly delays photoreceptor loss in a model for hereditary retinal degeneration.

Authors:  Ayse Sahaboglu; Melanie Barth; Enver Secer; Eva M Del Amo; Arto Urtti; Yvan Arsenijevic; Eberhart Zrenner; François Paquet-Durand
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

10.  A systematic analysis of the PARP protein family identifies new functions critical for cell physiology.

Authors:  Sejal Vyas; Melissa Chesarone-Cataldo; Tanya Todorova; Yun-Han Huang; Paul Chang
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  2 in total

1.  Reduced nuclear NAD+ drives DNA damage and subsequent immune activation in the retina.

Authors:  Emily E Brown; Michael J Scandura; Sudeep Mehrotra; Yekai Wang; Jianhai Du; Eric A Pierce
Journal:  Hum Mol Genet       Date:  2022-05-04       Impact factor: 5.121

2.  Inherited Retinal Degeneration: PARP-Dependent Activation of Calpain Requires CNG Channel Activity.

Authors:  Jie Yan; Alexander Günter; Soumyaparna Das; Regine Mühlfriedel; Stylianos Michalakis; Kangwei Jiao; Mathias W Seeliger; François Paquet-Durand
Journal:  Biomolecules       Date:  2022-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.